5th Annual Cell & Gene Therapy World Asia is a must-attend 2-day virtual conference on cell and gene therapy innovation and commercialization bringing together international and asia’s leading industry experts.

Dr Magali Taiel, Chief Medical Officer, will give an oral presentation on our lead product candidate LUMEVOQ® (GS010; lenadogene nolparvovec) as detailed below:


Wednesday 15th September 2021

Time:  3:45 pm SGT (9.45 AM-10.15 AM Paris Time)

Session:  Clinical Case Studies in Gene Therapy

Lumevoq Gene Therapy in Leber Hereditary Optic Neuropathy (LHON)

  • Examine LHON and its main clinical aspects
  • Late stage development of Lumevoq Gene Therapy and discussion of regulatory pathways
  • Pivotal studies Results and Discussion
  • Outline key learnings of Lumevoq gene therapy